{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:40:09Z","timestamp":1723563609774},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Cancer Research Foundation of the Department of Oncology"},{"name":"LIONS Cancerforskningsfond"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00701-020-04537-w","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T12:45:08Z","timestamp":1599741908000},"page":"333-342","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery"],"prefix":"10.1007","volume":"163","author":[{"given":"M.","family":"Stenman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Benmakhlouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Wers\u00e4ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Hatiboglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mayer-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Harmenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lindskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"issue":"9422","key":"4537_CR1","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","volume":"363","author":"DW Andrews","year":"2004","unstructured":"Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665\u20131672","journal-title":"Lancet"},{"issue":"2","key":"4537_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3171\/2017.3.JNS162532","volume":"129","author":"L Angelov","year":"2018","unstructured":"Angelov L, Mohammadi AM, Bennett EE et al (2018) Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases \u22652 cm. J Neurosurg 129(2):366\u2013382","journal-title":"J Neurosurg"},{"issue":"1","key":"4537_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0360-3016(96)85008-5","volume":"35","author":"RM Auchter","year":"1996","unstructured":"Auchter RM, Lamond JP, Alexander E et al (1996) A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 35(1):27\u201335","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"4537_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.clgc.2018.07.018","volume":"16","author":"PC Barata","year":"2018","unstructured":"Barata PC, Mendiratta P, Kotecha R et al (2018) Effect of switching systemic treatment after stereotactic radiosurgery for oligoprogressive, metastatic renal cell carcinoma. Clin Genitourin Cancer 16(5):413\u2013419","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"4537_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1634\/theoncologist.2018-0267","volume":"24","author":"E Calvo","year":"2019","unstructured":"Calvo E, Porta C, Gr\u00fcnwald V, Escudier B (2019) The current and evolving landscape of first-line treatments for advanced renal cell carcinoma. Oncologist 24(3):338\u2013348","journal-title":"Oncologist"},{"issue":"6","key":"4537_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/CCO.0000000000000484","volume":"30","author":"CM Carapella","year":"2018","unstructured":"Carapella CM, Gorgoglione N, Oppido PA (2018) The role of surgical resection in patients with brain metastases. Curr Opin Oncol 30(6):390\u2013395","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"4537_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ijrobp.2017.11.041","volume":"100","author":"L Chen","year":"2018","unstructured":"Chen L, Douglass J, Kleinberg L et al (2018) Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma. Int J Radiat Oncol Biol Phys 100(4):916\u2013925","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"4537_CR8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3171\/jns.2001.94.6.0899","volume":"94","author":"LS Chin","year":"2001","unstructured":"Chin LS, Ma L, DiBiase S (2001) Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg 94(6):899\u2013904","journal-title":"J Neurosurg"},{"issue":"3","key":"4537_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-008-9713-3","volume":"91","author":"HJ Choi","year":"2009","unstructured":"Choi HJ, Cho BC, Sohn JH et al (2009) Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC. J Neuro-Oncol 91(3):307\u2013313","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"4537_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.clgc.2017.05.010","volume":"15","author":"SY Choi","year":"2017","unstructured":"Choi SY, Yoo S, You D et al (2017) Prognostic factors for survival of patients with synchronous or metachronous brain metastasis of renal cell carcinoma. Clin Genitourin Cancer 15(6):717\u2013723","journal-title":"Clin Genitourin Cancer"},{"key":"4537_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.critrevonc.2018.06.002","volume":"128","author":"F De Felice","year":"2018","unstructured":"De Felice F, Tombolini V (2018) Radiation therapy in renal cell carcinoma. Crit Rev Oncol Hematol 128:82\u201387","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"4537_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1586\/ecp.11.1","volume":"4","author":"J Dietrich","year":"2011","unstructured":"Dietrich J, Rao K, Pastorino S, Kesari S (2011) Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol 4(2):233\u2013242","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"4537_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clgc.2012.11.001","volume":"11","author":"AZ Dudek","year":"2013","unstructured":"Dudek AZ, Raza A, Chi M et al (2013) Brain metastases from renal cell carcinoma in the era of tyrosine kinase inhibitors. Clin Genitourin Cancer 11(2):155\u2013160","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"4537_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/jrcr.jrcr_33_17","volume":"8","author":"A Fabiano","year":"2017","unstructured":"Fabiano A, Prasad D, Qiu J (2017) Adverse radiation effect in the brain during cancer radiotherapy. J Radiat Cancer Res 8(3):135\u2013140","journal-title":"J Radiat Cancer Res"},{"issue":"4","key":"4537_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/0360-3016(94)90098-1","volume":"28","author":"JC Flickinger","year":"1994","unstructured":"Flickinger JC, Kondziolka D, Lunsford LD et al (1994) A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28(4):797\u2013802","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"4537_CR16","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1200\/JCO.18.02218","volume":"37","author":"R Flippot","year":"2019","unstructured":"Flippot R, Dalban C, Laguerre B et al (2019) Safety and Efficacy of nivolumab in brain metastases from renal cell carcinoma: results of the GETUG-AFU 26 NIVOREN multicenter phase II study. J Clin Oncol 37(23):2008\u20132016","journal-title":"J Clin Oncol"},{"issue":"3","key":"4537_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","volume":"91","author":"S Goel","year":"2011","unstructured":"Goel S, Duda DG, Xu L et al (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91(3):1071\u20131121","journal-title":"Physiol Rev"},{"issue":"3","key":"4537_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/cncr.25452","volume":"117","author":"ME Gore","year":"2011","unstructured":"Gore ME, Hariharan S, Porta C et al (2011) Sunitinib in metastatic renal cell carcinoma patients with brain metastases. Cancer. 117(3):501\u2013509","journal-title":"Cancer."},{"key":"4537_CR19","doi-asserted-by":"crossref","unstructured":"Ha FJ, Spain L, Dowling A, et al.(2019) Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: an Australian multicenter study. Asia Pac J Clin Oncol 1-6. Epub ahead of print.","DOI":"10.1111\/ajco.13109"},{"issue":"4_suppl","key":"4537_CR20","first-page":"S185","volume":"4","author":"LM Halasz","year":"2013","unstructured":"Halasz LM, Rockhill JK (2013) Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases. Surg Neurol Int 4(4_suppl):S185\u2013S191","journal-title":"Surg Neurol Int"},{"key":"4537_CR21","first-page":"308","volume":"7","author":"MA Hatiboglu","year":"2013","unstructured":"Hatiboglu MA, Wildrick DM, Sawaya R (2013) The role of surgical resection in patients with brain metastases. Ecancermedicalscience. 7:308","journal-title":"Ecancermedicalscience."},{"issue":"4","key":"4537_CR22","doi-asserted-by":"publisher","first-page":"e935","DOI":"10.1016\/j.clgc.2018.03.015","volume":"16","author":"W Haque","year":"2018","unstructured":"Haque W, Verma V, Butler EB et al (2018) Utilization of stereotactic radiosurgery for renal cell carcinoma brain metastases. Clin Genitourin Cancer 16(4):e935\u2013e943","journal-title":"Clin Genitourin Cancer"},{"issue":"34","key":"4537_CR23","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","volume":"27","author":"DYC Heng","year":"2009","unstructured":"Heng DYC, Xie W, Regan MM et al (2009) Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol 27(34):5794\u20135799","journal-title":"J Clin Oncol"},{"issue":"4","key":"4537_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/neuros\/nyx225","volume":"82","author":"BR Hirshman","year":"2018","unstructured":"Hirshman BR, Wilson B, Ali MA et al (2018) Superior prognostic value of cumulative intracranial tumor volume relative to largest intracranial tumor volume for stereotactic radiosurgery-treated brain metastasis Patients. Neurosurgery. 82(4):473\u2013480","journal-title":"Neurosurgery."},{"issue":"9","key":"4537_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nm0901-987","volume":"7","author":"RK Jain","year":"2001","unstructured":"Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7(9):987\u2013989","journal-title":"Nat Med"},{"issue":"1","key":"4537_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3171\/2018.8.JNS182100","volume":"132","author":"A Juloori","year":"2019","unstructured":"Juloori A, Miller JA, Parsai S et al (2019) Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases. J Neurosurg 132(1):188\u2013196","journal-title":"J Neurosurg"},{"issue":"2","key":"4537_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11060-017-2442-8","volume":"133","author":"JM Kim","year":"2017","unstructured":"Kim JM, Miller JA, Kotecha R et al (2017) The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies. J Neuro-Oncol 133(2):357\u2013368","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"4537_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.clgc.2019.02.007","volume":"17","author":"G Klausner","year":"2019","unstructured":"Klausner G, Troussier I, Biau J et al (2019) Stereotactic radiation therapy for renal cell carcinoma brain metastases in the tyrosine kinase inhibitors era: outcomes of 120 patients. Clin Genitourin Cancer 17(3):191\u2013200","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"4537_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00066-014-0648-7","volume":"190","author":"M Kocher","year":"2014","unstructured":"Kocher M, Wittig A, Piroth MD et al (2014) Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190(6):521\u2013532","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"4537_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ijrobp.2005.07.980","volume":"64","author":"T Korytko","year":"2006","unstructured":"Korytko T, Radivoyevitch T, Colussi V et al (2006) 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64(2):419\u2013424","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4537_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3109\/0284186X.2014.939298","volume":"54","author":"G Kothari","year":"2015","unstructured":"Kothari G, Foroudi F, Gill S et al (2015) Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review. Acta Oncol 54(2):148\u2013157","journal-title":"Acta Oncol"},{"issue":"3_suppl","key":"4537_CR32","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","volume":"76","author":"YR Lawrence","year":"2010","unstructured":"Lawrence YR, Li XA, el Naqa I et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76(3_suppl):S20\u2013S27","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"4537_CR33","first-page":"585","volume":"134","author":"L Leksell","year":"1968","unstructured":"Leksell L (1968) Cerebral radiosurgery. I. Gammathalanotomy in two cases of intractable pain. Acta Chir Scand 134(8):585\u2013595","journal-title":"Acta Chir Scand"},{"issue":"1","key":"4537_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13014-018-1083-1","volume":"13","author":"P Lesueur","year":"2018","unstructured":"Lesueur P, Lequesne J, Barraux V et al (2018) Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer). Radiat Oncol 13(1):138","journal-title":"Radiat Oncol"},{"issue":"1","key":"4537_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctrv.2013.05.002","volume":"40","author":"B Lippitz","year":"2014","unstructured":"Lippitz B, Lindquist C, Paddick I et al (2014) Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev 40(1):48\u201359","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"4537_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s000660050027","volume":"175","author":"M Mariotta","year":"1999","unstructured":"Mariotta M, Perewusnyk G, Koechli OR et al (1999) Dexamethasone-induced enhancement of resistance to ionizing radiation and chemotherapeutic agents in human tumor cells. Strahlenther Onkol 175(8):392\u2013396","journal-title":"Strahlenther Onkol"},{"key":"4537_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1748-717X-6-48","volume":"6","author":"G Minniti","year":"2011","unstructured":"Minniti G, Clarke E, Lanzetta G et al (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48","journal-title":"Radiat Oncol"},{"issue":"1","key":"4537_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.rpor.2018.11.001","volume":"24","author":"I Morales-Orue","year":"2019","unstructured":"Morales-Orue I, Chicas-Sett R, Lara PC (2019) Nanoparticles as a promising method to enhance the abscopal effect in the era of new targeted therapies. Rep Pract Oncol Radiother 24(1):86\u201391","journal-title":"Rep Pract Oncol Radiother"},{"key":"4537_CR39","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1016\/j.wneu.2019.03.193","volume":"127","author":"S-AL Morris","year":"2019","unstructured":"Morris S-AL, Zhu P, Rao M et al (2019) Gamma knife stereotactic radiosurgery in combination with bevacizumab for recurrent glioblastoma. World Neurosurg 127:e523\u2013e533","journal-title":"World Neurosurg"},{"issue":"8","key":"4537_CR40","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1200\/JCO.1999.17.8.2530","volume":"17","author":"RJ Motzer","year":"1999","unstructured":"Motzer RJ, Mazumdar M, Bacik J et al (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17(8):2530\u20132540","journal-title":"J Clin Oncol"},{"issue":"6","key":"4537_CR41","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s10147-019-01407-z","volume":"24","author":"HC Nam","year":"2019","unstructured":"Nam HC, Sung PS, Song DS et al (2019) Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma. Int J Clin Oncol 24(6):666\u2013676","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"4537_CR42","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.1007\/s13277-015-3337-y","volume":"36","author":"C Nieder","year":"2015","unstructured":"Nieder C, Dalhaug A, Haukland E et al (2015) Tumor marker analyses in patients with brain metastases: patterns of practice and implications for survival prediction research. Tumour Biol 36(8):6471\u20136476","journal-title":"Tumour Biol"},{"issue":"5","key":"4537_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.14740\/jocmr3746","volume":"11","author":"C Nieder","year":"2019","unstructured":"Nieder C, Dalhaug A, Pawinski A (2019) External validation of the LABBM score in patients with brain metastases. J Clin Med Res 11(5):321\u2013325","journal-title":"J Clin Med Res"},{"issue":"8","key":"4537_CR44","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.clon.2014.03.006","volume":"26","author":"C Nieder","year":"2014","unstructured":"Nieder C, Marienhagen K, Dalhaug A et al (2014) Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement. Clin Oncol (R Coll Radiol) 26(8):447\u2013452","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4537_CR45","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10147-018-1312-5","volume":"23","author":"T Okuda","year":"2018","unstructured":"Okuda T, Hayashi N, Takahashi M et al (2018) Clinical outcomes of brain metastases from hepatocellular carcinoma: a multicenter retrospective study and a literature review. Int J Clin Oncol 23:1095\u20131100","journal-title":"Int J Clin Oncol"},{"issue":"Pt 5","key":"4537_CR46","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/brain\/aww046","volume":"139","author":"KL Pitter","year":"2016","unstructured":"Pitter KL, Tamagno I, Alikhanyan K et al (2016) Corticosteroids compromise survival in glioblastoma. Brain 139(Pt 5):1458\u20131471","journal-title":"Brain"},{"issue":"10","key":"4537_CR47","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.21873\/anticanres.11106","volume":"36","author":"N Shaverdian","year":"2016","unstructured":"Shaverdian N, Wang J, Levin-Epstein R et al (2016) Pro-inflammatory state portends poor outcomes with stereotactic radiosurgery for brain metastases. Anticancer Res 36(10):5333\u20135337","journal-title":"Anticancer Res"},{"key":"4537_CR48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4103\/sni.sni_480_17","volume":"9","author":"G Sinclair","year":"2018","unstructured":"Sinclair G, Benmakhlouf H, Brigui M et al (2018) The concept of rapid rescue radiosurgery in the acute management of critically located brain metastases: a retrospective short-term outcome analysis. Surg Neurol Int 9:218","journal-title":"Surg Neurol Int"},{"key":"4537_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.25259\/SNI_176_2019","volume":"10","author":"G Sinclair","year":"2019","unstructured":"Sinclair G, Benmakhlouf H, Martin H et al (2019) Adaptive hypofractionated gamma knife radiosurgery in the acute management of brainstem metastases. Surg Neurol Int 10:14","journal-title":"Surg Neurol Int"},{"issue":"2","key":"4537_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","volume":"123","author":"PK Sneed","year":"2015","unstructured":"Sneed PK, Mendez J, Vemer-van den Hoek JGM et al (2015) Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg 123(2):373\u2013386","journal-title":"J Neurosurg"},{"issue":"3","key":"4537_CR51","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","volume":"77","author":"PW Sperduto","year":"2010","unstructured":"Sperduto PW, Chao ST, Sneed PK et al (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77(3):655\u2013661","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4537_CR52","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ijrobp.2018.04.006","volume":"101","author":"PW Sperduto","year":"2018","unstructured":"Sperduto PW, Deegan BJ, Li J et al (2018) Effect of targeted therapies on prognostic factors, patterns of care, and survival in patients with renal cell carcinoma and brain metastases. Int J Radiat Oncol Biol Phys 101(4):845\u2013853","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"4537_CR53","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/neuonc\/noy099","volume":"20","author":"PW Sperduto","year":"2018","unstructured":"Sperduto PW, Deegan BJ, Li J et al (2018) Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool. Neuro-oncology. 20(12):1652\u20131660","journal-title":"Neuro-oncology."},{"issue":"5","key":"4537_CR54","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1464-410X.2010.09895.x","volume":"108","author":"M Staehler","year":"2011","unstructured":"Staehler M, Haseke N, Nuhn P et al (2011) Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma. BJU Int 108(5):673\u2013678","journal-title":"BJU Int"},{"issue":"3","key":"4537_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0841-7","volume":"31","author":"M Stenman","year":"2014","unstructured":"Stenman M, Laurell A, Lindskog M (2014) Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma. Med Oncol 31(3):841","journal-title":"Med Oncol"},{"issue":"3","key":"4537_CR56","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.radonc.2018.04.028","volume":"127","author":"M Stenman","year":"2018","unstructured":"Stenman M, Sinclair G, Paavola P et al (2018) Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014. Radiother Oncol 127(3):501\u2013506","journal-title":"Radiother Oncol"},{"key":"4537_CR57","doi-asserted-by":"crossref","unstructured":"Torrens M, Chung C, Chung H-T, et al.(2014) Standardization of terminology in stereotactic radiosurgery: report from the Standardization Committee of the International Leksell Gamma Knife Society: special topic. J Neurosurg (121_suppl):S2-15.","DOI":"10.3171\/2014.7.GKS141199"},{"issue":"2","key":"4537_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1158\/1078-0432.CCR-16-0037","volume":"24","author":"C Vanpouille-Box","year":"2018","unstructured":"Vanpouille-Box C, Formenti SC, Demaria S (2018) Toward precision radiotherapy for use with immune checkpoint blockers. Clin Cancer Res 24(2):259\u2013265","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4537_CR59","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/COC.0b013e31825d59db","volume":"36","author":"J Verma","year":"2013","unstructured":"Verma J, Jonasch E, Allen PK et al (2013) The impact of tyrosine kinase inhibitors on the multimodality treatment of brain metastases from renal cell carcinoma. Am J Clin Oncol 36(6):620\u2013624","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"4537_CR60","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.clgc.2013.04.012","volume":"11","author":"MM Vickers","year":"2013","unstructured":"Vickers MM, Al-Harbi H, Choueiri TK et al (2013) Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium. Clin Genitourin Cancer 11(3):311\u2013315","journal-title":"Clin Genitourin Cancer"},{"key":"4537_CR61","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/1471-2407-10-480","volume":"10","author":"UM Vogl","year":"2010","unstructured":"Vogl UM, Bojic M, Lamm W et al (2010) Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma. BMC Cancer 10:480","journal-title":"BMC Cancer"},{"issue":"2","key":"4537_CR62","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1016\/j.clgc.2018.11.006","volume":"17","author":"Z Wardak","year":"2019","unstructured":"Wardak Z, Christie A, Bowman A et al (2019) Stereotactic radiosurgery for multiple brain metastases from renal-cell carcinoma. Clin Genitourin Cancer 17(2):e273\u2013e280","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"4537_CR63","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0360-3016(99)00549-0","volume":"46","author":"E Weltman","year":"2000","unstructured":"Weltman E, Salvajoli JV, Brandt RA et al (2000) Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 46(5):1155\u20131161","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4537_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1023\/B:JORA.0000010892.99686.9e","volume":"1","author":"E Weltman","year":"1998","unstructured":"Weltman E, Salvajoli JV, Oliveira VC et al (1998) Score index for stereotactic radiosurgery of brain metastases. J Radiosurg 1:89\u201395","journal-title":"J Radiosurg"},{"issue":"4","key":"4537_CR65","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3171\/jns.2002.97.4.0785","volume":"97","author":"B Wowra","year":"2002","unstructured":"Wowra B, Siebels M, Muacevic A et al (2002) Repeated gamma knife surgery for multiple brain metastases from renal cell carcinoma. J Neurosurg 97(4):785\u2013793","journal-title":"J Neurosurg"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-020-04537-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-020-04537-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-020-04537-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:10:06Z","timestamp":1723561806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-020-04537-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4537"],"URL":"https:\/\/doi.org\/10.1007\/s00701-020-04537-w","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"type":"print","value":"0001-6268"},{"type":"electronic","value":"0942-0940"}],"subject":[],"published":{"date-parts":[[2020,9,9]]},"assertion":[{"value":"8 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr Maria Stenman received speaker\u2019s honoraria from Pfizer NORCC Kopenhagen, in 2017 and 2019.Ulrika Harmenberg participated in advisory boards for Pfizer, Novartis, Bayer, GlaxoSmithKline and IPSEN and has received an unrestricted grant from Novartis.Magnus Lindskog participated in advisory boards for and received speaker\u2019s honoraria from Pfizer, BMS and IPSEN.All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (name of institute\/committee) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.For this type of (retrospective) study, formal consent is not required.This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}